TRANSGLIOMA
New treatments for glioblastoma through a cross-border translational research platform
01/2016 - 1b
Základné informácie
-
Stručný popis poradenskej firmyTRANSGLIOMA faces the challenges identified by the EU2020 plan and the Italy-Slovenia Program. It is an implementation of the Interreg GLIOMA project, which discovered new cancer stem cell markers which will be used in a clinical environment for early diagnosis, response to treatment and as a therapeutic target. The innovative approach will allow single patients to receive a personalised treatment, contributing to an improvement in the quality of life of patients with brain tumours.
- Plánovaný začiatok projektu 01.09.2017 Predpokladaný koniec projektu 29.02.2020
- trvanie 29 (month (s))
rozpočet
- Celkový rozpočet programu / výzvy 1302252 Projekt Financovanie EÚ 1106915 Percento: 85
partneri
Dokumenty
-
pre tento záznam momentálne nie sú k dispozícii žiadne dokumenty